ADGRL4 and glioblastoma: ADGRL4/ELTD1 is overexpressed, compared to normal adjacent endothelium, in tumour-associated endothelial cells in several common tumour types (head and neck, renal, colorectal, ovarian and brain cancers)4,5 as well as in glioblastoma tumour cells9.